These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1117 related items for PubMed ID: 32621798

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y, Liu S, Luo H, Wu S, Wei H, Tang Z, Li X, Lv X, Zou C.
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [Abstract] [Full Text] [Related]

  • 3. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A.
    Huang Y, Guan Y, Zhang X.
    Mol Biotechnol; 2024 Aug; 66(8):1942-1953. PubMed ID: 37498409
    [Abstract] [Full Text] [Related]

  • 4. METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.
    Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN, Chen ZH, Zeng ZL, Wang F, Zheng J, Chen D, Li B, Kang TB, Xie D, Lin D, Ju HQ, Xu RH.
    Mol Cancer; 2019 Jun 24; 18(1):112. PubMed ID: 31230592
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.
    Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, Pan L, Su G.
    J Hematol Oncol; 2019 Dec 09; 12(1):135. PubMed ID: 31818312
    [Abstract] [Full Text] [Related]

  • 7. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B, Song C, Yang L, Cui R, Cheng X, Zhang Z, Zhao G.
    Mol Cancer; 2019 Oct 13; 18(1):142. PubMed ID: 31607270
    [Abstract] [Full Text] [Related]

  • 8. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J, Xie H, Ying Y, Chen H, Yan H, He L, Xu M, Xu X, Liang Z, Liu B, Wang X, Zheng X, Xie L.
    Mol Cancer; 2020 Oct 29; 19(1):152. PubMed ID: 33121495
    [Abstract] [Full Text] [Related]

  • 9. METTL3 mediated m6A modification plays an oncogenic role in cutaneous squamous cell carcinoma by regulating ΔNp63.
    Zhou R, Gao Y, Lv D, Wang C, Wang D, Li Q.
    Biochem Biophys Res Commun; 2019 Jul 23; 515(2):310-317. PubMed ID: 31153635
    [Abstract] [Full Text] [Related]

  • 10. METTL3/YTHDF2 m6 A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.
    Xie H, Li J, Ying Y, Yan H, Jin K, Ma X, He L, Xu X, Liu B, Wang X, Zheng X, Xie L.
    J Cell Mol Med; 2020 Apr 23; 24(7):4092-4104. PubMed ID: 32126149
    [Abstract] [Full Text] [Related]

  • 11. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM, Qi FF, Wang J, Duan YY, Zhao LL, Wang YD, Zhang TC, Liao XH.
    Int J Mol Sci; 2022 Jun 09; 23(12):. PubMed ID: 35742899
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dynamic m6A mRNA methylation reveals the role of METTL3-m6A-CDCP1 signaling axis in chemical carcinogenesis.
    Yang F, Jin H, Que B, Chao Y, Zhang H, Ying X, Zhou Z, Yuan Z, Su J, Wu B, Zhang W, Qi D, Chen D, Min W, Lin S, Ji W.
    Oncogene; 2019 Jun 09; 38(24):4755-4772. PubMed ID: 30796352
    [Abstract] [Full Text] [Related]

  • 14. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1.
    Bai W, Xiao G, Xie G, Chen Z, Xu X, Zeng J, Xie J.
    Thorac Cancer; 2024 Sep 09; 15(26):1871-1881. PubMed ID: 39090761
    [Abstract] [Full Text] [Related]

  • 15. m6A methyltransferase METTL3 promotes oral squamous cell carcinoma progression through enhancement of IGF2BP2-mediated SLC7A11 mRNA stability.
    Xu L, Li Q, Wang Y, Wang L, Guo Y, Yang R, Zhao N, Ge N, Wang Y, Guo C.
    Am J Cancer Res; 2021 Sep 09; 11(11):5282-5298. PubMed ID: 34873461
    [Abstract] [Full Text] [Related]

  • 16. Verbascoside inhibits oral squamous cell carcinoma cell proliferation, migration, and invasion by the methyltransferase 3-mediated microRNA-31-5p/homeodomain interacting protein kinase 2 axis.
    Huang Y, Wu W, Zhang X.
    Arch Oral Biol; 2024 Aug 09; 164():105979. PubMed ID: 38744201
    [Abstract] [Full Text] [Related]

  • 17. METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1.
    Song D, Wang Q, Yan Z, Su M, Zhang H, Shi L, Fan Y, Zhang Q, Yang H, Zhang D, Liu Q.
    Biol Direct; 2024 Jun 07; 19(1):44. PubMed ID: 38849910
    [Abstract] [Full Text] [Related]

  • 18. LAMA3 Promotes Tumorigenesis of Oral Squamous Cell Carcinoma by METTL3-Mediated N6-Methyladenosine Modification.
    Ning B, Mei Y.
    Crit Rev Immunol; 2024 Jun 07; 44(2):49-59. PubMed ID: 38305336
    [Abstract] [Full Text] [Related]

  • 19. RNA m6 A methylation regulates uveal melanoma cell proliferation, migration, and invasion by targeting c-Met.
    Luo G, Xu W, Zhao Y, Jin S, Wang S, Liu Q, Chen X, Wang J, Dong F, Hu DN, Reinach PS, Yan D.
    J Cell Physiol; 2020 Oct 07; 235(10):7107-7119. PubMed ID: 32017066
    [Abstract] [Full Text] [Related]

  • 20. Mettl3-mediated m6A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration.
    Jiang FQ, Liu K, Chen JX, Cao Y, Chen WY, Zhao WL, Song GH, Liang CQ, Zhou YM, Huang HL, Huang RJ, Zhao H, Park KS, Ju Z, Cai D, Qi XF.
    Elife; 2022 Nov 18; 11():. PubMed ID: 36399125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.